FindTrial
Sign In

Treatment outcomes in tuberculosis patients in Udupi District using blood tests.

Prospective cohort evaluation of therapeutic outcomes among newly diagnosed tuberculosis patients on daily drug regimen under RNTCP in Udupi district, using Clinical, Biochemical, Nutritional and Hematological Markers.

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
CTRI
Registry ID
CTRI/2019/11/021839
Enrollment
810
Registered
2019-11-01
Start date
Unknown
Completion date
Unknown
Last updated
2021-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: A150- Tuberculosis of lung

Interventions

Intervention1: Not Applicable: Not Applicable

Sponsors

Hithaish kumar R N
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: All patients registered as new TB cases for daily drug regimen from 3 to 70 years of both pulmonary and extra pulmonary under RNTCP. Both paediatric and adult patients of either sex. Patients who will continue to stay in study area and available for one year follow up.

Exclusion criteria

Exclusion criteria: Previously treated patients who are currently on daily drug regimen either Drug sensitive or Drug resistant

Design outcomes

Primary

MeasureTime frame
Cure from Tuberculosis DiseaseTimepoint: 0,2,6 months—

Secondary

MeasureTime frame
Relapse of patients who have been Declared as cure or successfully treatedTimepoint: 18 months—

Countries

India

Contacts

Public ContactDr Chythra R Rao

Kasturba Medical College,Manipal, Manipal Academy Of Higher Education.

chythra.raj@manipal.edu9448857793

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026